Physician profile
Thomas Olinger
NPI 1124407556
$696.54
in general payments reported to CMS, 2019-2025
10 companies · $332 in 2025
The $332 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $253 · 2022: $46.08 · 2024: $65.28 · 2025: $332.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $397.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $129.94 | 2025 | Trumatch |
| Sientra, INC. | $127.86 | 2021 | |
| Organogenesis INC. | $125.00 | 2021 | |
| Mentor Worldwide LLC | $109.64 | 2022-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Smith+Nephew, INC. | $69.94 | 2022-2025 | Collagenase Santyl, Grafix Pl |
| Davol INC. | $36.52 | 2025 | Phasix Mesh |
| Acera Surgical, INC. | $27.31 | 2025 | Restrata Wound Matrix |
| Tela Bio, INC. | $26.22 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Abbvie INC. | $23.38 | 2025 | |
| Integra Lifesciences Corporation | $20.73 | 2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Olinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.